1. Non-invasive biomarkers for response and survival prediction in patients with advanced solid tumours treated with immune checkpoint inhibitors (ICIs). (October 2022) Authors: Bernatowicz, K.; Vieito, M.; Berche, R.; Alonso, G.; Galvao, V.; Oberoi, H.K.; Braña, I.; Saavedra, O.; Muñoz-Couselo, E.; Grussu, F.; Belen, A.; Serna, G.; Rotxes, M.; Sanz, M.; Tabernero, J.; Toledo, R.; Nuciforo, P.; Garralda, E.; Perez-Lopez, R. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Peripheral blood neutrophil/lymphocyte ratio as a prognostic factor in triple negative breast cancer. (November 2022) Authors: Mendes, A.S.; Muñoz-Couselo, E.; Simões, J.; Gonçalves, F.; Ferreira, G.; Araújo, A. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Targeting FGFR pathway in breast cancer. (February 2018) Authors: Perez-Garcia, J.; Muñoz-Couselo, E.; Soberino, J.; Racca, F.; Cortes, J. Journal: Breast Issue: Volume 37(2018) Page Start: 126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗